TLV:KMDA

Kamada Ltd. · TLV · Healthcare · ILS · FY for 2024

Figures on this page computed 2026-11-08 12:44 UTC

Last close

n/aILA

Market data

26.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
ILA
- computed
- Computed from the filing for 2024
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
9.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
22.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
0.04Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
ILA
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

113

2023-12-31 to 2024-12-31100 at the start113

Sales: 100.00 on 2023-12-31 to 112.93 on 2024-12-31, up 13%.

Profit

175

2023-12-31 to 2024-12-31100 at the start175

Profit: 100.00 on 2023-12-31 to 174.58 on 2024-12-31, up 75%.

Shares in issue

102

2023-12-31 to 2024-12-31100 at the start102

Shares in issue: 100.00 on 2023-12-31 to 102.21 on 2024-12-31, up 2%.

Sales is at 113, Profit is at 175, Shares in issue is at 102, against 100 in 2023.

Sales is at 113, Profit is at 175, Shares in issue is at 102, against 100 in 2023.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

Sales, where the first year is 100113
Source
computed
Statement
income
Fiscal year
2024
Reported in
USD
Profit, where the first year is 100175
Source
computed
Statement
income
Fiscal year
2024
Reported in
USD
Shares in issue, where the first year is 100102
Source
computed
Statement
income
Fiscal year
2024
Reported in
USD